Back

Corrigendum to: Targeting the CCL2–CCR2 axis for atheroprotection

European Heart Journal

28 April 2022
Organised by: Logo
Read full article
ESC Journals CARDIOVASCULAR PHARMACOLOGY BASIC SCIENCE Pharmacology and Pharmacotherapy
You may be interested in
thumbnail
Congress Presentation
Global deficiency in the inflammatory chemokine receptors 1,2,3 and 5 ameliorates atherosclerosis and selectively modulates aortic myeloid cell phenotype
26 August 2023
thumbnail
Congress Presentation
Novel aspects of chemokine receptor signalling in cardiovascular inflammation
21 April 2018
thumbnail
Congress Session
Clonal hematopoiesis of indeterminate potential in cardiovascular disease: from atherosclerosis to heart failure
17 May 2025
thumbnail
Webinar
Quantification of coronary inflammation using coronary CT angiography to improve patient risk prediction and stratification
27 September 2021

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources